Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present a dynamic symposium on diagnostic and management strategies for carotid artery disease and stroke.
|CME: Management of Carotid Artery Stenosis & Acute Stroke
Meet our speakers:
Course DirectorsMichael R. Jaff, DO
Medical Director, Vascular Center
Kenneth Rosenfield, MD
Section Head, Vascular Medicine and Intervention
Management of Carotid Artery Stenosis & Acute Stroke is a dynamic symposium designed to analyze new clinical trial data and enhance physician's diagnostic and management strategies for patients with significant carotid artery disease.
Carotid endarterectomy (CEA) has been an effective therapy for patients with extracranial carotid artery disease for several decades. More recently, an explosion of clinical trials data has demonstrated equivalence in safety and efficacy of carotid artery stent (CAS) deployment. In addition, due to improvements in medical interventions for the treatment of risk factors for stroke and established atherosclerosis, many clinicians view pharmacotherapy as the primary treatment for patients with significant carotid artery disease. This has led to confusion among practicing clinicians regarding the appropriate strategies for the treatment of patients with extracranial carotid artery disease.
During this event, expert faculty focus on practical clinical guidance for both specialists and primary care physicians on screening criteria, imaging modalities, multidisciplinary patient management, and much more.
- Describe patient characteristics and risk factors that should trigger screening for carotid artery stenosis
- Identify the most appropriate patients for primary medical therapies, carotid endarterectomy, or carotid artery stenting based on current guidleines and clinical studies
- Describe the role of medical intervention in the management of patients with asymptomatic carotid artery stenosis
- Understand the strategies for the diagnosis and treatment options for acute stroke
The Massachusetts Medical Society designates this live activity for a maximum of 6.75 AMA PRA Category 1 CreditsTM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.